Meridian Bioscience to Participate in Panel Presentation at RBC Capital Markets 2008 Healthcare Conference

Meridian Bioscience, Inc., Cincinnati, Ohio (NASDAQ: VIVO) today announced that Jack Kraeutler, Chief Executive Officer, will be presenting as a panel participant at the RBC Capital Markets 2008 Healthcare Conference, held at the Westin Times Square Hotel in New York. The panel titled, Getting to the Point (of Care) is scheduled from 9-9:55 a.m. ET. on December 11, 2008 in Panel Room 2. The information provided during the session may not have been previously disclosed.

A live webcast of the panel will be available on the Events section of the Investor Relations page of Meridian’s website at www.meridianbioscience.com. A replay of the webcast will be available for 30 days following the event.

Certain statements may be made at the conference that may be considered "forward-looking statements" within the meaning of Section 27A of the Securities Act of 1933 and Section 21E of the Securities Exchange Act of 1934. Actual results could differ materially from any predictions that may be made. Additional information regarding factors that could cause such differences shall be referenced at the conference.

Meridian is a fully integrated life science company that manufactures, markets and distributes a broad range of innovative diagnostic test kits, purified reagents and related products and offers biopharmaceutical enabling technologies. Utilizing a variety of methods, these products and diagnostic tests provide accuracy, simplicity and speed in the early diagnosis and treatment of common medical conditions, such as gastrointestinal, viral and respiratory infections. Meridian’s diagnostic products are used outside of the human body and require little or no special equipment. The Company's products are designed to enhance patient well-being while reducing the total outcome costs of healthcare. Meridian has strong market positions in the areas of gastrointestinal and upper respiratory infections, serology, parasitology and fungal disease diagnosis. In addition, Meridian is a supplier of rare reagents, specialty biologicals and related technologies used by biopharmaceutical companies engaged in research for new drugs and vaccines. The Company markets its products and technologies to hospitals, reference laboratories, research centers, veterinary testing centers, physician offices, diagnostics manufacturers and biotech companies in more than 60 countries around the world. The Company’s shares are traded through NASDAQ’s Global Select Market, symbol VIVO. Meridian's website address is www.meridianbioscience.com.